5 ms·
Data which no doubt is the result of research and engineering funded with public money. Thus, it should be in the public domain and unencumbered with patents i
by snvzz 6y ago
Data which no doubt is the result of research and engineering funded with public money.
Thus, it should be in the public domain and unencumbered with patents in the first place.
- dpwm 6y agoAnd in many cases will be bought as a developed product with public funds.
- tinus_hn 6y agoNo, these companies are not funded with public money.
- maze-le 6y agoNo? > BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162 https://www.wallstreet-online.de/nachricht/12930907-biontech-to-receive-up-to-375m-funding-from-german-federal-ministry-of-education-and-research-to-support-covid-19-vaccine-program-bnt162/all https://www.wallstreet-online.de/nachricht/12930907-biontech... > US government and Pfizer reach $1.95 billion deal to produce millions of Covid-19 vaccine doses https://edition.cnn.com/2020/07/22/health/pfizer-covid-19-vaccine-government-contract/index.html https://edition.cnn.com/2020/07/22/health/pfizer-covid-19-va...
- adriancr 6y ago> to Support COVID-19 Vaccine Program BNT162 Emphasis on support That doesn't mean the sum is equivalent to the full R&D cost or that the company actually agreed to give the IP developed. Most likely they could have developed even without public funding but not on the expedited timeline.
- bildung 6y agoDo you have any actual evidence for this? BioNTech has about 1k employees strong and got about 375 million Euros. Even if everyone would exclusively work on the vaccine for the whole time, which obviously didn't happen, that amounts to over 700k€ per seat for half a year. In an industry that isn't exactly capital intensive, i.e. the biggest part of expenses will be salaries.
- adriancr 6y agoPlease read your own articles before posting. Your article it states clearly what the funding was for: > The goal of the initiative is the expansion of vaccine development and manufacturing capabilities in Germany, as well as the expansion of the number of participants in late-stage clinical trials.
- bildung 6y agoWhat you quoted is the shortend version of the goals of the funding program, here is a more complete description: https://www.bmbf.de/foerderungen/bekanntmachung-3035.html https://www.bmbf.de/foerderungen/bekanntmachung-3035.html The program is funding clinical trials 1 to 3, having bigger cohorts for trials 2 and 3, and scaling up production while trials are still in progress. In short: Everything that makes vaccine development expensive. Finding the actual vaccine candidates is the cheap part.
- adriancr 6y ago> Finding the actual vaccine candidates is the cheap part. Do you have any sources on that?
- bildung 6y agoSee here: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(18)30346-2/fulltext https://www.thelancet.com/journals/langlo/article/PIIS2214-1... Going from zero to preclinical is about 1/3 of the costs of going from preclinical to phase 2. Phase 3 is not part of this study, neither is parallel production.
- refurb 6y agoThe German funding is funding. The Pfizer funding is just a pre-purchase agreement.
- meragrin_ 6y agoAccording to the German article, they were already in phase 3 and they had not received any of that grant money. Seems to me, it is more about vaccine production at this point.
- bildung 6y agoBiontech's research definitely was funded with public money, over 300€ million, in fact: https://investors.biontech.de/de/news-releases/news-release-details/biontech-erhaelt-bmbf-foerderung-von-bis-zu-375-millionen-euro https://investors.biontech.de/de/news-releases/news-release-...
- meragrin_ 6y agoAccording to the article, they were already in phase 3 and they had not received any of that grant money. Seems to me, it is more about vaccine production at this point.
- bildung 6y agoCorrect, though keep mind that this was explicitly demanded for this program: https://www.bmbf.de/foerderungen/bekanntmachung-3035.html https://www.bmbf.de/foerderungen/bekanntmachung-3035.html chapter 4, second bullet point. That doesn't mean they don't get reinbursed for phases 1-3. Of course I don't know for certain, I do have past experience with federal funding in Germany, though. Considering that the company has a history of funding from this source ("BioNTech is already an old friend in our research funding. We - the BMBF - have been promoting this company since it was founded in 2007") https://www.bmbf.de/de/deutschland-kann-innovation-13125.html https://www.bmbf.de/de/deutschland-kann-innovation-13125.htm... my interpretation is that this was a calculated advance payment.
- tinus_hn 6y agoThey got €300 million but that doesn’t mean the project cost €300 million. This is a pretty normal arrangement where government induces companies to do something by paying at least up to half the cost while the company gets to reap the rewards. I’ve seen it happen in tech but I’m sure it happens in different fields. Of course its a mutually beneficial arrangement, otherwise that would be pretty dumb for a government to do, right?
- waihtis 6y agoI can guarantee if there are any government funding instruments in place in the respective countries of operation, one way or another it will be gouged by the big corps. Example from my home country: the government heavily subsidized the biggest telco’s new cyber security center a couple years back, because it was an ”technological innovation” that would ”bring jobs”. The services provided through this are of course private (as are gains.) The talent and resources of big corp will usually outwit government policy.
- oblio 6y agoThat's a radical proposal. Instead the countries mass buying these vaccines should have a condition of annulling the patents upon purchase. The EU buys 300 million doses, they pay 300 million x unit plus a 1 time cost for the patents. As a result all the patents developed as part of the development of this vaccine are voided. Company becomes richer than it already is, humanity gets richer with this new, public knowledge.
- deleted 6y ago[deleted]
- oblio 6y agoI love how HN is against software patents yet my much more lenient pharma proposal is downvoted :-))
- bluGill 6y agoHN isn't anything. Some users are against software patents, some are not. A downvote comes from some unknown person with some unknown opinion on the subject.
- oblio 6y agoTrue, but that's assuming that there isn't a local culture that develops wherever people congregate, even online. HN, as designed, definitely leans towards entrepreneurs, risk takers, people who rebel against authority, etc. Nothing wrong with that, we just have to acknowledge it :-)
- refurb 6y agoBy that logic if a tech start-up takes a business grant from the local govt of say $500k, but later raises $10M from private investors, the entire company and all of its technology should be public domain? Really? A drop of public funding means the entire company is public domain?
- hoseja 6y agoThese aren't startups. They are multi-billion pharma corporations.
- fennecfoxen 6y agoWhat precisely is the structural, legal, moral, or other practical difference?
- refurb 6y agoAnd that changes things because...? Just replace “raised $10M from investors” with “put in $100M of their own money”. Point still stands, no?
- unnouinceput 6y agoMilitary secrets are funded with public money. Should them be too public domain?
- the-smug-one 6y agoIf by "public domain" you mean "public knowledge", then it should indirectly be public knowledge through elected officials. Do you have any reason to believe that the military should be treated equally to healthcare funded by the public? I mean, is this meant to be some sort of 'gotcha'?
- unnouinceput 6y agoyes
- xtracto 6y agoSetec Astronomy.
- a1369209993 6y ago> Military secrets are funded with public money. Should them be too public domain? Yes.
- echlebek 6y agoThat's a false equivalence. This type of data doesn't represent a security threat.
- bagacrap 6y agoPfizer didn't take public money for development of this vaccine --- Moderna did. And by public, I mean from the US taxpayer. No American company got funding from the Russian government.
- godelski 6y agoFYI, they did take German money[0]. But there's still the question of what does "public" mean here. [0]https://www.bloomberg.com/news/articles/2020-11-09/pfizer-vaccine-s-funding-came-from-berlin-not-washington https://www.bloomberg.com/news/articles/2020-11-09/pfizer-va...
- Aunche 6y agoThey're getting public money to fund public benefits like opening up businesses. If the vaccine single-handedly revitalizes the economy, they don't get paid for that either.